AI and quantum computing will accelerate medical breakthroughs, potentially doubling human lifespan and revolutionizing disease treatment. Alphabet is uniquely positioned to lead in healthspan and ...

Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Isomorphic Labs says its first artificial-intelligence-designed medicines are nearly ready for human testing. What Happened: Isomorphic Labs President ...

Google parent Alphabet's shares closed largely flat on Thursday after the company beat Wall Street's expectations on earnings and revenue. The company said it would increase spending on artificial ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...

Alphabet shares fell as much as 9% in after-hours trading Tuesday after the company reported fourth-quarter results that missed on revenue expectations. The company also announced that it plans to ...

Alphabet faces high investor expectations following a year of significant stock growth, with the core focus being proof that massive capital investments in AI. Wall Street expects a strong quarter, ...

Human Investing LLC decreased its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,506 shares of the ...

Alphabet today announced Q4 2024 earnings with $96.47 billion in revenue. These numbers range from October to December, with the company also reporting fiscal year 2024 results. Q4 was a strong ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $370.75, a high ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...